Hepatocyte VDR protects against cirrhosis-associated bone loss via repression of the FN1/Integrin αv signaling.

IF 13
Li Cen, Chenxi Tang, Bingru Lin, Xin Song, Xiaofeng Zhang, Peihao Liu, Chengfu Xu, Chaohui Yu
{"title":"Hepatocyte VDR protects against cirrhosis-associated bone loss via repression of the FN1/Integrin αv signaling.","authors":"Li Cen, Chenxi Tang, Bingru Lin, Xin Song, Xiaofeng Zhang, Peihao Liu, Chengfu Xu, Chaohui Yu","doi":"10.1016/j.jare.2026.08.006","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Vitamin D and its receptor (VDR) are essential for liver homeostasis and bone development, and their dysfunction has been implicated in cirrhosis-associated osteoporosis.</p><p><strong>Objectives: </strong>This study aimed to elucidate the molecular mechanisms linking hepatic injury to bone fragility.</p><p><strong>Methods: </strong>We examined VDR dysfunction in cirrhotic patients and in a murine model of cirrhosis. Hepatocyte-specific VDR knockout mice were used to determine the contribution of hepatic VDR to bone loss during cirrhosis.</p><p><strong>Results: </strong>Analysis of UK Biobank data, a Chinese patient cohort, and murine cirrhosis models demonstrated that reduced serum 25-hydroxyvitamin D (25-OHD) correlates with hepatic fibroinflammation and low bone mass. However, vitamin D<sub>3</sub> supplementation failed to restore bone density, indicating noncanonical VDR signaling in bone homeostasis. Hepatic VDR expression declined with progressive fibrosis, and hepatocyte-specific VDR deletion exacerbated trabecular bone loss through enhanced osteoclastogenesis without altering bone formation. Mechanistically, VDR deficiency upregulated hepatocyte fibronectin (FN1), which trafficked to bone marrow and activated osteoclasts via integrin αv. Serum FN1 levels were elevated in cirrhosis patients, correlated with reduced vertebral bone density, and associated with osteoclast activity in mice. Genetic ablation or hepatocyte-specific knockdown of FN1 attenuated bone resorption and improved trabecular architecture. Pharmacologic inhibition of the FN1-integrin αv pathway with CWHM12 reduced osteoclast activity, rescued bone mass, and concurrently ameliorated hepatic fibrosis.</p><p><strong>Conclusion: </strong>These findings establish hepatic VDR as a central modulator of cirrhosis-associated osteoporosis through FN1-mediated integrin signaling. Targeting the VDR-FN1-integrin αv axis offers a dual therapeutic opportunity for managing both hepatic fibrosis and osteoporosis in cirrhosis.</p>","PeriodicalId":94063,"journal":{"name":"Journal of advanced research","volume":" ","pages":""},"PeriodicalIF":13.0000,"publicationDate":"2026-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of advanced research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jare.2026.08.006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Vitamin D and its receptor (VDR) are essential for liver homeostasis and bone development, and their dysfunction has been implicated in cirrhosis-associated osteoporosis.

Objectives: This study aimed to elucidate the molecular mechanisms linking hepatic injury to bone fragility.

Methods: We examined VDR dysfunction in cirrhotic patients and in a murine model of cirrhosis. Hepatocyte-specific VDR knockout mice were used to determine the contribution of hepatic VDR to bone loss during cirrhosis.

Results: Analysis of UK Biobank data, a Chinese patient cohort, and murine cirrhosis models demonstrated that reduced serum 25-hydroxyvitamin D (25-OHD) correlates with hepatic fibroinflammation and low bone mass. However, vitamin D3 supplementation failed to restore bone density, indicating noncanonical VDR signaling in bone homeostasis. Hepatic VDR expression declined with progressive fibrosis, and hepatocyte-specific VDR deletion exacerbated trabecular bone loss through enhanced osteoclastogenesis without altering bone formation. Mechanistically, VDR deficiency upregulated hepatocyte fibronectin (FN1), which trafficked to bone marrow and activated osteoclasts via integrin αv. Serum FN1 levels were elevated in cirrhosis patients, correlated with reduced vertebral bone density, and associated with osteoclast activity in mice. Genetic ablation or hepatocyte-specific knockdown of FN1 attenuated bone resorption and improved trabecular architecture. Pharmacologic inhibition of the FN1-integrin αv pathway with CWHM12 reduced osteoclast activity, rescued bone mass, and concurrently ameliorated hepatic fibrosis.

Conclusion: These findings establish hepatic VDR as a central modulator of cirrhosis-associated osteoporosis through FN1-mediated integrin signaling. Targeting the VDR-FN1-integrin αv axis offers a dual therapeutic opportunity for managing both hepatic fibrosis and osteoporosis in cirrhosis.

肝细胞VDR通过抑制FN1/整合素αv信号传导来保护肝硬化相关的骨质流失。
维生素D及其受体(VDR)对肝脏稳态和骨骼发育至关重要,其功能障碍与肝硬化相关的骨质疏松症有关。目的:探讨肝损伤与骨脆性的分子机制。方法:我们在肝硬化患者和肝硬化小鼠模型中检测了VDR功能障碍。使用肝细胞特异性VDR敲除小鼠来确定肝脏VDR对肝硬化期间骨质流失的贡献。结果:对英国生物银行数据、中国患者队列和小鼠肝硬化模型的分析表明,血清25-羟基维生素D (25-OHD)降低与肝纤维炎症和低骨量相关。然而,补充维生素D3未能恢复骨密度,表明骨稳态中的非规范VDR信号。肝脏VDR表达随进行性纤维化而下降,肝细胞特异性VDR缺失通过增强破骨细胞发生而加剧小梁骨丢失,但不改变骨形成。从机制上讲,VDR缺乏上调肝细胞纤维连接蛋白(FN1), FN1通过整合素αv转运到骨髓,激活破骨细胞。肝硬化患者血清FN1水平升高,与椎体骨密度降低相关,并与小鼠破骨细胞活性相关。基因消融或肝细胞特异性敲除FN1可减弱骨吸收并改善小梁结构。CWHM12对fn1 -整合素αv通路的药理学抑制可降低破骨细胞活性,挽救骨量,同时改善肝纤维化。结论:这些发现证实肝脏VDR是通过fn1介导的整合素信号传导介导肝硬化相关骨质疏松的中枢调节剂。靶向vdr - fn1 -整合素αv轴为肝硬化肝纤维化和骨质疏松症的治疗提供了双重治疗机会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书